Herendeen Paul

Avg. Two Year Performance

No purchase track record
13% Avg. Sale Return
6% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(< 1%)29%19%21%0%
Purchase Success Rate2 of 33 of 32 of 31 of 30 of 3
Average Sale Return(6%)(< 1%)19%9%13%
Sale Success Rate5 of 94 of 93 of 92 of 94 of 9
Drugs » Biotechnology

Exec. V.P. and CFO, Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drug Delivery

EVP and CFO:

Holdings: 298.61K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drug Manufacturers - Major

Exec. V.P. and CFO:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--